Guselkumab Superior to Ustekinumab for Joint and Skin Outcomes in PsAMarch 14, 2024Psoriatic Arthritis
Certain Gut Microbiota and Serum Metabolites May Protect Against PsAMarch 14, 2024Psoriatic Arthritis
Bimekizumab Shows Long-term Benefits in PsA with Inadequate Response or Intolerance to TNFiMarch 14, 2024Psoriatic Arthritis
Ixekizumab Improves Distal Interphalangeal Joint Involvement and Adjacent Nail Psoriasis in PsAMarch 14, 2024Psoriatic Arthritis
Rheumatology NewsAI’s Future and Current Role in RheumatologyMarch 14, 2024Business of MedicineRheumatoid ArthritisPsoriatic ArthritisAnkylosing spondylitisSpondyloarthropathies
Rheumatology NewsLeflunomide: A Fresh Look at an Old DrugMarch 8, 2024Rheumatoid ArthritisPsoriatic ArthritisLupus & Connective Tissue Diseases
Rheumatology NewsHow Good are Tools to Screen for Spondyloarthritis in Patients With Psoriasis, Uveitis, IBD?March 4, 2024SpondyloarthropathiesAnkylosing spondylitisPsoriatic Arthritis
Rheumatology NewsStudy Evaluates Factors Driving Fatigue in Patients With Psoriasis, PsAMarch 4, 2024Psoriatic Arthritis
Commentary: PsA Comorbidities and Treatment Safety and Effectiveness, March 2024February 27, 2024Psoriatic Arthritis
Rheumatology NewsFDA Approves 10th Humira Biosimilar, With InterchangeabilityFebruary 27, 2024Rheumatoid ArthritisSpondyloarthropathiesAnkylosing spondylitisPsoriatic ArthritisPediatrics
Rheumatology NewsIxekizumab’s Final Safety Results Reported Across 25 Trials in Psoriasis, PsA, Axial SpAFebruary 27, 2024Psoriatic ArthritisSpondyloarthropathiesAnkylosing spondylitis
Rheumatology NewsUse of Biologics for Psoriasis Found to Confer a Survival BenefitFebruary 23, 2024Psoriatic ArthritisMixed Topics
